Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Phase III trials on Kyowa Hakko's olopatidine HCl complete

June 7, 1996

SJC13: LPS-stimulated adhesion inhibitor

June 7, 1996

Searle discloses LTA4 hydrolase inhibitors

June 7, 1996

Sanofi Winthrop research reveals elastase inhibitors

May 31, 1996

Small-molecule alpha4 integrin antagonists generation disclosed by Biogen

May 31, 1996

Nikken Chemicals reports antiallergic/antiinflammatory N-hydroxyureas

May 31, 1996

Medeva owns U.S. rights to acrivastine/pseudoephedrine HCI

May 31, 1996

FDA approval for RPR's new triamcinolone acetonide formulation

May 31, 1996

Hyaluronic acid and derivatives described by Hyal

May 31, 1996

Pirfenidone clinical trials in pulmonary fibrosis

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
Deals and an M&A strengthen end-of-year numbers
BioWorld
Two large deals and an acquisition, totaling about $4.64 billion in all, are helping wrap up what’s turning out to be a strong year. Through the first 11 months...
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...